[1] HE W Z， JIANG Z H， SUO Q L. Application of supercritical fluids technology in drugs delivery system preparation [J]. Chemistry (化学通报)， 2003， 66（1）: 27-32.
[2] OKAMOTO H， DANJO K. Application of supercritical fluid to preparation of powders of high-molecular weight drugs for inhalation [J]. Adv Drug Deliver Rev， 2008， 60（3）: 433-446.
[3] PASQUALI I， BETTINI R， GIORDANO F. Supercritical fluid technologies: An innovative approach for manipulating the solid-state of pharmaceuticals [J]. Adv Drug Deliver Rev， 2008， 60（3）: 399-410.
[4] MISHIMA K. Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas [J]. Adv Drug Deliver Rev， 2008， 60（3）: 411-432.
[5] KRUKONIS V J. Supercritical fluid nucleation of difficlt-to-comminute solids[C]. AichE Annual Meeting， San Francisco， CA. 1984.
[6] HU G Q， ZHANG C L， CHEN Q， et al. Micronization of griseofulvin by rapid expansion of supercritical solution containing cosolvent [J]. Chin J Pharm (中国医药工业杂志)， 2005， 36(4): 211-213.
[7] MOUSSA A B， KSIBI H， TENAUD C， et al. Parametric study on the nozzle geometry to control the supercritical fluid expansion [J]. Int J Therm Sci， 2005， 44（8）: 774-786.
[8] HIRUNSIT P， HUANG Z， SRINOPHAKUN T， et al. Particle formation of ibuprofen-supercritical CO₂ system from rapid expansion of supercritical solutions (RESS): A mathematical model [J]. Powder Technol， 2005， 154（2-3）: 83-94.
[9] TANDYA A， DEHGHANI F， FOSTER N R. Micronization of cyclosporine using dense gas techniques [J]. J Supercrit Fluids， 2006， 37（3）: 272-278.
[10] TURK M， UPPER G， HILS P. Formation of composite drug-polymer particles by co-precipitation during the rapid expansion of supercritical fluids [J]. J Supercrit Fluids， 2006， 39(2): 253-263.
[11] THAKUR R， GUPTA R B. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process [J]. Int J Pharm， 2006， 308（1-2）: 190-199.
[12] HUANG Z， SUN G B， CHIEW Y C， et al. Formation of ultrafine aspirin particles through rapid expansion of supercritical solutions (RESS) [J]. Powder Technol， 2005， 160（2）: 127-134.
[13] SU C S， TANG M， CHEN Y P. Micronization of nabumetone using the rapid expansion of supercritical solution (RESS) process [J]. J Supercrit Fluids， 2009， 50(1): 69-76.
[14] NURAY Y A， EBNEM T A， ONUR D A， et al. Micronization of salicylic acid and taxol (paclitaxel) by rapid expansion of supercritical fluids (RESS) [J]. J Supercrit Fluids， 2007， 41（3）: 440-451.
[15] CHEN X Q， CHEN T S， YU H J， et al. Study on the process of formation of fine α-asarone and ibuprofen particle by rapid expansion of supercritical solution [J]. J Ningxia Univ (Nat Sci Ed) (宁夏大学学报自然科学版)， 2001， 22(2): 155-157.
[16] ALESSI P， CORTESI A， KIKIC I， et al. Particle production of steroid drugs using supercritical fluid processing [J]. Ind Eng Chem Res， 1996， 35（12）: 4718-4726.
[17] NIJLEN T V， BRENNAN K， MOOTER G V， et al. Improvement of the dissolution rate of artemisinin by means of supercritical fluids technology and solid dispersions [J]. Int J Pharm， 2003， 254（2）: 173-181.
[18] BETTINI R， ROSSI A， LAVEZZINI E， et al. Thermal and morphological characterization of micronized acetylsalicylic acid powders prepared by rapid expansion of a supercritical solution [J]. J Therm Anal Calorim， 2003， 73（2）: 487-497.
[19] PABLO G D， JEAN W T， YEO S D， et al. Application of supercritical fluids for the production of sustained delivery devices [J]. J Controlled Release， 1993， 24（1-3）: 27-44.
[20] GUNEY O， AKGERMAN A. Synthesis of controlled-release products in supercritical medium [J]. AIChE， 2002， 48(4): 856-866.
[21] SHINOZAKI H， OGUCHI T， SUZUKI S， et al. Micronization and polymorphic conversion of tolbutamide and barbital by rapid expansionof supercritical solutions[J]. Drug Dev Ind Pharm， 2006， 32（7）: 877-891.
[22] MEZIANI M J， PATHAK P， DESAI T， et al. Supercritical fluid processing of nanoparticles from biodegradable and biocompatible polymers [J]. Ind Eng Chem Res， 2006， 45（10）: 3420-3424.
[23] YOUNG T J， JOHNSTON K P， PACE G W， et al. Phospholipid-stabilized nanoparticles of cyclosporine A by rapid expansion from supercritical to aqueous solution [J]. AAPS Pharm Sci Tech， 2003， 5(1): 1-15.
[24] WANG T J， TSUTSUMI A， HASEGAWA H， et al. Mechanism of particle coating granulation with RESS process in a fluided bed [J]. Powder Tech， 2001，118（3）: 229-235.
[25] SENCAR P， SRCIC S， KNEZ Z， et al. Improvement of nifedipine dissolution characteristics using supercritical CO₂ [J]. Int J Pharm， 1997， 148（2）: 123-130.
[26] KERC J， SRCIC S， KNEZ Z， et al. Micronization of drugs using supercritical carbon dioxide [J]. Int J Pharm， 1999，182（1）: 33-39.
[27] ANA R C D， CHRISTELLE R， ARLETTE V G， et al. Preparation of acetazolamide composite microparticles by supercriticalanti-solvent techniques [J]. Int J Pharm， 2007， 332（1-2）: 132-139.
[28] GALLAGHER P M， COFFEY M P， KRUKONIS V J， et al. Gas antisolvent recrystalllization: new process to recrystallize compounds insoluble in supercritical fluids [C]. HOSHSTON K P， PENNINGER J M L (eds. ). Supercritical fluid science and technology. Washington DC: ACS Symposium Series， no. 406， 1989: 334-354.
[29] BAKHBAKHI Y， CHARPENTIER P A， ROHANI S. Experimental study of the GAS process for producing microparticles of beclomethasone-17，21-dipropionate suitable for pulmonary delivery [J]. Int J Pharm， 2006， 309（1-2）: 71-80.
[30] MOCHIZUKE S， TERAMOTO A， YAMASHITA F， et al. Size-controlled recrystallization of fullerene by gas-antisolvent process [J]. J Mater Sci， 2010， 45(6): 1588-1594.
[31] YEO S D， KIN M S， LEE J C. Recrystallization of sulfathiazole and chlorpropamide using the supercritical fluid antisolvent process [J]. J Supercrit Fluid， 2003， 25（2）: 143-154.
[32] MONEGHINI M， KIKIC I， VOINOVICH D， et al. Study of solid state of carbamazepine after processing with gas anti-solvent technique [J]. Eur J Pharm Biopharm， 2003， 56（2）:281-289.
[33] YEO S D， LIM G B， DEBENEDETTI P G. Formation of microparticulate protein powder using supercritical fluid antisolvent [J]. Biotec Bioeng， 1993， 41(3): 341-346.
[34] CHEN K X， ZHANG X Y， PAN J， et al. Recrystallization of andrographolide using the supercritical fluid antisolvent process [J]. J Cryst Growth， 2005， 274（1-2）: 226-232.
[35] YORK P， HANNA M. Particles engineering by supercritical technologies for powder inhalation drug delivery. Proceeding of Respiratory Drug Delivery V， Pheonis[C]: Buffalo Grove: Interpharm Preess, 1996： 231-239.
[36] REHMAN M， SHEKUNOV B Y， YORK P， et al. Solubility and precipitation of nicotinic acid in supercritical carbon dioxide [J]. J Pharm Sci， 2001， 90(10): 1570-1582.
[37] RODIER E， LOCHARD H， SAUCEAU M， et al. A three step supercritical process to improve the dissolution rate of Eflucimibe [J]. Eur J Pharm Sci， 2005， 26（2）: 184-193.
[38] PYO D G， LIM C， CHO D， et al. Size prediction of recombinant human growth hormonenanoparticles produced by supercritical fluid precipitation [J]. Anal Bioanal Chem， 2007， 387（3）: 901-907.
[39] BOUCHARD A， JOVANOVIC N， HOFLAND G W， et al. Ways of manipulating the polymorphism of glycine during supercritical fluid crystallization [J]. J Supercit Fluid， 2008， 44（3）: 422-432.
[40] LI Y， YANG D J， CHEN S L， et al. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods [J]. Pharm Res， 2008， 25(3): 563-577.
[41] SACHA G A， SCHMITT W J， NAIL S L. Identification of critical process variables affecting particle size following precipitation using a supercritical fluid [J]. Pharm Dev Technol， 2006， 11（2）: 187-194.
[42] KIM Y H， SIOUTAS C， FINE P， et al. Effect of albumin on physical characteristics of drug particles produced by supercritical fluid technology [J]. Powder Technol， 2008， 182（3）: 354-363.
[43] KUNASTITCHAI S， PICHERT L， SARISUTA N， et al. Application of aerosol solvent extraction system (ASES) process for preparation of liposomes in a dry and reconstitutable form [J]. Int J Pharm， 2006， 316 (1-2): 93-101.
[44] MORIBE K， FUKINO M， TOZUKA Y， et al. Prednisolone multicomponent nanoparticles preparation by aerosol solvent extracton system [J]. Int J Pharm， 2009， 380 (1-2): 201-205.
[45] REVERCHON E， MARCO I D， PORTA G D. Rifampicin microparticles production by supercritical antisolvent precipitation [J]. Int J Pharm， 2002， 243（1-2）: 83-91.
[46] WANG Y L， DAVE R N， PFEFFER R. Polymer coating/encapsulation of nanoparticles using a supercritical anti-solvent process [J]. J Supercrit Fluids， 2004， 28（1）: 85-99.
[47] CHATTOPADHAY P， GUPTA R B. Production of antibiotic nanoparticles using supercritical CO₂ as antisolvent with enhanced mass transfer [J]. Ind Eng Chem Res，2001， 40（16）: 3530-3539.
[48] PATHAK P， MEZIANI M J， DESAI T， et al. Formation and stabilization of ibuprofen nanoparticles in supercritical fluid processing [J]. J Supercrit Fluids，2006， 37（3）: 279-286.
[49] GONG K， VIBOONKIAT R， REHMAN I U， et al. Formation and characterization of porous indomethacin-PVP coprecipitates prepared using solvent-free supercritical fluid processing [J]. J Pharm Sci，2005， 94(12): 2583-2590.
[50] HAO J Y， WHITAKER M J， SERHATKULU G， et al. Supercritical fluid assisted melting of poly(ethylene glycol): a new solvent-free route to microparticles [J]. J Mater Chem， 2005， 15（11）: 1148-1153.
[51] LIU H， FINN N， YATES M Z. Encapsulation and sustained release of a model drug indomethacin， using CO₂-based microencapsulation [J]. Langmuir， 2005， 21（1）: 379-385.
[52] REVERCHON E， PPRTA G D. Terbutaline microparticles suitable for aerosol delivery produced by supercritical assisted atomization [J]. Int J Pharm， 2003， 258（1-2）: 1-9.
[53] REVERCHON E， ANTONACCI A. Chitosan microparticles production by supercritical fluid processing [J]. Ind Eng Chem Res， 2006， 45（16）: 5722-5728.
[54] ELVIRA C， FANOVICH A， FERNANDEZ M， et al. Evaluation of drug delivery characteristics of microspheres of PMMA-PCL-cholesterol obtained by supercritical-CO₂ impregnation and by dissolution-evaporation techniques [J]. J Controlled Release， 2004， 99（2）: 231-240.
[55] KHALED H， MICHAEL T， WAHL M A. Drug loading into-cyclodextrin granules using a supercritical fluid process for improved drug dissolution [J]. Eur J Pharm Sci， 2008， 33（3）: 306-312.
[56] THIERING R， DEHGHANI F， FOSTER N R. Current issues relating to anti-solvent micronisation techniques and their extension to industrial scales [J]. J Supercrit Fluids， 2001， 21 (2): 159-177.